{
  "zip": "33609",
  "sector": "Healthcare",
  "fullTimeEmployees": 2,
  "longBusinessSummary": "Inhibitor Therapeutics Inc. operates as a pharmaceutical development company that discovers, develops, and plans to commercialize therapeutics to inhibit the progression of cancerous and non-cancerous proliferation disorders in the United States. The company's Hedgehog signaling pathway is a primary regulator of cellular processes in vertebrates, including cell differentiation, tissue polarity, and cell proliferation. It focuses on developing its lead product, SUBA-Itraconazole, a patented oral formulation for prostate and lung cancer. The company was formerly known as HedgePath Pharmaceuticals, Inc. and changed its name to Inhibitor Therapeutics Inc. in August 2019. Inhibitor Therapeutics Inc. was founded in 1992 and is based in Tampa, Florida.",
  "city": "Tampa",
  "phone": "813 864 2559",
  "state": "FL",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.inhibitortx.com",
  "maxAge": 1,
  "address1": "4830 West Kennedy Boulevard",
  "fax": "813 509 2417",
  "industry": "Biotechnology",
  "address2": "Suite 600",
  "previousClose": 0.04,
  "regularMarketOpen": 0.04,
  "twoHundredDayAverage": 0.050417267,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.0478,
  "navPrice": null,
  "averageDailyVolume10Day": 11400,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.04,
  "fiftyDayAverage": 0.037818182,
  "trailingAnnualDividendRate": null,
  "open": 0.04,
  "averageVolume10days": 11400,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.031512,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.038,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 82010,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 17859802,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 16753,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.038,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 82010,
  "fiftyTwoWeekHigh": 0.138,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.03,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 0.0478,
  "exchange": "PNK",
  "shortName": "INHIBITOR THERAPEUTICS INC",
  "longName": "Inhibitor Therapeutics, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "INTI",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_369680",
  "uuid": "fe7e17dd-fe3d-3d39-983f-61295e0babc4",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 373636000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.016,
  "sharesShort": 19880,
  "sharesPercentSharesOut": 0.0023,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -1838456,
  "trailingEps": -0.01,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.78296995,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": 0.07,
  "sharesShortPreviousMonthDate": 1260835200,
  "floatShares": 77899343,
  "enterpriseValue": 18911194,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": 1263513600,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": 0.0036000002,
  "sharesShortPriorMonth": 40,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.04,
  "logo_url": "https://logo.clearbit.com/inhibitortx.com"
}